CAH

Ticker

CAH

Congressional Trades

by 4 members

Ticker Intelligence Brief

Who in Congress traded CAH, when, and what happened after?

A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.

Latest receipt

Ro Khanna

SELL · 2026-02-05

Largest range

$50K – $100K

Jonathan Jackson

Slowest filing

123d

John James

Best vs SPY

66.8%

John James

Buys

56%

Sells

44%

Total Volume

$139K

midpoint

Unique Traders

members

Party Breakdown

Democrats5 · 56%

Republicans4 · 44%

Party Trading Divergence

Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCE

Bar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.

Democrat ←

Month

→ Republican

1▲

Jan '24

—

May '24

1▲

—

Jun '24

1▲

Aug '24

—

Sep '24

0▲1▼

—

Apr '25

1▲

0▲1▼

Sep '25

—

0▲1▼

Jan '26

—

0▲1▼

Feb '26

—

Democrats2▲3▼Net sellers

Republicans3▲1▼Net buyers

Net buyingNet selling⚡ Party split

🏛️ Federal Contracts

all →

2026-06-18$19K
Department of Veterans Affairs
MARIBAVIR (LIVTENCITY) 200MG
2026-06-18$0
Department of Veterans Affairs
RADIOPHARMACEUTICALS FOR BUFFALO VA
2026-06-16$19K
Department of Veterans Affairs
MARIBAVIR (LIVTENCITY) 200MG (NDC 64764-0800-56)
2026-06-15$18K
Department of Veterans Affairs
COMPRESSION DEVICE LEASE - 82106 SCD SMARTFLOW US
2026-06-08$46K
Department of Health and Human Services
CARDINAL HEALTH 108, LLC:1296676 [26-001378]
2026-05-29$655K
Department of Veterans Affairs
RADIOPHARMACEUTICAL SUPPLIES EO 14398
2026-05-19$19K
Department of Veterans Affairs
*EMERGENCY* MARIBAVIR 200MG (NDC 64764-0800-56) FOR THE NEW YORK HARBOR , BROOKLYN VA MEDICAL CENTER.
2026-05-05$107K
Department of Veterans Affairs
RADIOPHARMACEUTICALS - MODIFICATION TO EXERCISE FAR 52.217-8 FOR A PERIOD FROM 05-01-2026 THROUGH 07-31-2026.
2026-05-05$17K
Department of Veterans Affairs
ARCALYST MEDICATION
2026-04-21$147K
Department of Veterans Affairs
FLUDEOXYGLUCOSE FDG F 18 - PET CT DOSE

💼 Lobbying Filings

all →

2026-04-20$1.3M
CARDINAL HEALTH INC
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act. Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade p
2026-04-20$120K
CARDINAL HEALTH
Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy
2026-04-20$80K
CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP)
General issues related to drug shortages, supply chain Federal budget issues
2026-04-20$30K
CARDINAL HEALTH INC.
Health care and FDA/agriculture appropriations. Enteral nutrition.
2026-04-17$60K
CARDINAL HEALTH INC.
General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. Pharmaceutical tariffs
2026-04-17$24K
CARDINAL HEALTH INC.
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations. Tariff-related matters regarding the distribution and sale of pharmaceutical and m
2026-01-20$740K
CARDINAL HEALTH INC
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act). Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to tariffs, tr
2026-01-20$120K
CARDINAL HEALTH
Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy
2026-01-20$80K
CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP)
General issues related to drug shortages, supply chain Federal budget issues
2026-01-20$30K
CARDINAL HEALTH INC.
Health care and FDA/agriculture appropriations. Enteral nutrition.

Congressional Momentum

buy vs. sell pressureACCUMULATING

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days

No trades

Last 90 Days

No trades

All-Time

▲77

5 buys9 total4 sells

$107K buys · $32K sells

Cumulative Net Position (buy vol − sell vol)

+$75K

2024-019 trades plotted2026-02

Best Timers

avg excess return vs SPY · CAH trades only3 members w/ alpha data

Excess return = stock price change minus SPY change over the same holding window.Congress avg: +29.8%· 100% of traders beat SPY on this name

Top Alpha Generators

D:1R:2House:3

underperformed SPY|beat SPY

1st

John James

+55.8%

3×

2nd

Robert Bresnahan

+17.3%

1×

3rd

Ro Khanna

+16.1%

4×

Worst Timers

bottom 3 by avg excess return

underperformed SPY|beat SPY

Ro Khanna

+16.1%

4×

Robert Bresnahan

+17.3%

1×

John James

+55.8%

3×

Worst single trade: Ro Khanna (-16.7%)Best single trade: John James (+66.8%)

Timing Fingerprint

filing delay vs. excess return over SPY · 8 tradesCongress avg +31.2% vs SPY

Each dot = one disclosed trade. X-axis = days between trade and STOCK Act filing.Y-axis = return above (or below) SPY over the subsequent holding window. Upper-right = late filers who beat the market.

75% of trades beat SPYavg excess +31.2%avg delay 44d4 buys4 sellsBuySellOther· dot size ∝ trade size

Trade Activity Timeline

Congressional buys & sells by month · last 9 months w/ activity

24/01

24/05

24/06

24/08

24/09

25/04

25/09

26/01

26/02

BuysSellsOtherHigh-volume month

Who Moved First

each row = one member · sorted by earliest disclosed trade

4 buyers ·2 sellers

BuySellOtherDot size ∝ trade size · top 4 most-active traders shown

Seasonal Rhythm

Congress buy/sell pressure by month & year

Each cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.

Net buyingNet sellingNo trades · number = trade count

Peak buy month: Jan · Peak sell month: Sep

Congressional Conviction Timeline

net positioning · alpha track recordBULLISH

5 buys4 sellscumulative α +201.8%9mo tracked

Monthly Net Flow (Buys − Sells)

Cumulative Excess Return on Congressional Buys vs SPY

All Disclosed Trades

Date	Member	Action	Amount	Filing Delay	Receipt
2026-02-05	DRo Khanna	SELL	$1K – $15K	32d	receipt →
2026-01-23	DRo Khanna	SELL	$1K – $15K	14d	receipt →
2025-09-05	DRo Khanna	SELL	$1K – $15K	28d	receipt →
2025-04-08	RRobert Bresnahan	BUY	$1K – $15K	30d	receipt →
2024-09-04	RJohn James	SELL	$1K – $15K	2d	receipt →
2024-08-02	DRo Khanna	BUY	$1K – $15K	35d	receipt →
2024-06-03	RJohn James	BUY	$1K – $15K	91d	receipt →
2024-05-02	RJohn James	BUY	$1K – $15K	123d	receipt →
2024-01-12	DJonathan Jackson	BUY	$50K – $100K	24d	receipt →